chevron_leftBack
As of 18 June 2026, Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. has a market cap of $2.0B USD, ranking #7054 globally and #1725 in China.
It ranks #567 in the Healthcare sector, and #222 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$2.0BUSD
13.55B CNY
Enterprise Value
$1.82BUSD
12.33B CNY
Revenue (TTM)
$160.82MUSD
1.09B CNY
EBITDA (TTM)
$70.58MUSD
476.93M CNY
Net Income (TTM)
$63.02MUSD
425.83M CNY
EBITDA Margin
44%
Profit Margin
39%
PE Ratio
31.8
Forward PE
27.8
PS Ratio
12.5
PB Ratio
4.8
EV/EBITDA
25.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jianming He
open_in_new
Employees
1,808
Founded
2002
Website
wolwobiotech.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.8% | -2.3% | -0.4% | -13% | -27% | 30% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300357
浙江我武生物科技股份有限公司 Class A
ISIN: CNE100001R58
Shares Out.:
Shares Outstanding:
523.584M1
Shares Float:
269.199M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
25.40 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$54.0B
3K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.78B
2K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.53B
1K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.81B
838%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.56B
726%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.02B
699%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
38K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
27K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
18K%
|
97.4
|
|
SIX: RO
|
$323.08B
16K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.5B
14K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.99B
14K%
218.9B CHF
|
20.5
|
chevron_leftBack